Publication | Closed Access
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
493
Citations
4
References
2012
Year
Ocular DiseaseVitreous BodyOphthalmologySurgeryLeast 3GlaucomaDiabetic Macular EdemaMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1